Of note, despite CD276 overexpression in TAMs resulted in increase of EMR1+ macrophages in BLCA tumors, no overt difference was observed in EMR1+ macrophages recruitment treated with R428 in control or CD276 cKI mice (Fig. 6k, l). The gene discussed is ADGRE1; the disease is bladder transitional cell carcinoma.